Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

22 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Influence of combined C-peptide and insulin administration on renal function and metabolic control in diabetes type 1.
Johansson BL, Kernell A, Sjöberg S, Wahren J. Johansson BL, et al. Among authors: kernell a. J Clin Endocrinol Metab. 1993 Oct;77(4):976-81. doi: 10.1210/jcem.77.4.8408474. J Clin Endocrinol Metab. 1993. PMID: 8408474 Clinical Trial.
Vitreous fluorophotometry in juvenile diabetics with and without retinopathy in relation to metabolic control: insulin antibodies and c-peptide levels.
Kernell A, Ludvigsson J, Finnström K. Kernell A, et al. Acta Ophthalmol (Copenh). 1990 Aug;68(4):415-20. doi: 10.1111/j.1755-3768.1990.tb01669.x. Acta Ophthalmol (Copenh). 1990. PMID: 2220357
Influence of metabolic control on the blood-retinal barrier in streptozocin diabetic rats.
Kernell A, Dahlkvist H, Arnqvist H, Ludvigsson J. Kernell A, et al. Graefes Arch Clin Exp Ophthalmol. 1985;222(4-5):179-81. doi: 10.1007/BF02133669. Graefes Arch Clin Exp Ophthalmol. 1985. PMID: 15835015
Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with Type 1 diabetes mellitus.
Johansson BL, Borg K, Fernqvist-Forbes E, Kernell A, Odergren T, Wahren J. Johansson BL, et al. Among authors: kernell a. Diabet Med. 2000 Mar;17(3):181-9. doi: 10.1046/j.1464-5491.2000.00274.x. Diabet Med. 2000. PMID: 10784221 Clinical Trial.
Randomised placebo-controlled trial of human recombinant insulin-like growth factor I plus intensive insulin therapy in adolescents with insulin-dependent diabetes mellitus.
Acerini CL, Patton CM, Savage MO, Kernell A, Westphal O, Dunger DB. Acerini CL, et al. Among authors: kernell a. Lancet. 1997 Oct 25;350(9086):1199-204. doi: 10.1016/S0140-6736(97)06467-2. Lancet. 1997. PMID: 9652560 Clinical Trial.
Treatment with CSII in two infants with neonatal diabetes mellitus.
Olinder AL, Kernell A, Smide B. Olinder AL, et al. Among authors: kernell a. Pediatr Diabetes. 2006 Oct;7(5):284-8. doi: 10.1111/j.1399-5448.2006.00203.x. Pediatr Diabetes. 2006. PMID: 17054451
Missed bolus doses: devastating for metabolic control in CSII-treated adolescents with type 1 diabetes.
Olinder AL, Kernell A, Smide B. Olinder AL, et al. Among authors: kernell a. Pediatr Diabetes. 2009 Apr;10(2):142-8. doi: 10.1111/j.1399-5448.2008.00462.x. Epub 2008 Oct 24. Pediatr Diabetes. 2009. PMID: 19175898
Blood-retinal barriers in juvenile diabetics in relation to early clinical manifestations, HLA-DR types, and metabolic control.
Kernell A, Ludvigsson J. Kernell A, et al. Graefes Arch Clin Exp Ophthalmol. 1985;222(4-5):250-3. doi: 10.1007/BF02133690. Graefes Arch Clin Exp Ophthalmol. 1985. PMID: 3856546
Effect of insulin treatment on the blood-retinal barrier in rats with streptozocin-induced diabetes.
Kernell A, Arnqvist H. Kernell A, et al. Arch Ophthalmol. 1983 Jun;101(6):968-70. doi: 10.1001/archopht.1983.01040010968025. Arch Ophthalmol. 1983. PMID: 6344848
Superoxide dismutase in the anterior chamber and the vitreous of diabetic patients.
Kernell A, Lundh BL, Marklund SL, Skoog KO, Björkstén B. Kernell A, et al. Invest Ophthalmol Vis Sci. 1992 Oct;33(11):3131-5. Invest Ophthalmol Vis Sci. 1992. PMID: 1399417
22 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback